(Press-News.org) October 6, 2025 (Washington, DC)—The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), today announced that the Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) has awarded five grants totaling more than $2.5 million to interdisciplinary research teams. Concurrently, the two partners have launched ATF-BSI’s fifth round of philanthropic funding via a new request for proposals (RFP) related to sarcoidosis research.
ATF-BSI’s fourth cohort of awardees spans five funded projects (listed below). Each project is associated with an institution with which the project’s lead investigator is affiliated. Some funded projects include investigators and researchers at additional institutions.
• Institution: University of California, San Francisco, US
Lead investigator: K. Mark Ansel, PhD, Associate Professor of Microbiology & Immunology
Project: Revealing pathogenic signatures in sarcoidosis using single-cell genomics
• Institution: University of Minho, Portugal
Lead investigator: Agostinho Carvalho, PhD, Principal Investigator and Vice Director at the School of Medicine’s Life and Health Sciences Research Institute
Project: (Dys)regulation of phagosomal dynamics in sarcoidosis pathogenesis
• Institution: Yale University, US
Lead investigator: Changwan Ryu, MD, Assistant Professor, School of Medicine
Project: mtDNA-TLR9 induce fibroblast activation in stage IV sarcoidosis
• Institution: University of Wisconsin-Madison, US
Lead investigator: Bridget Shields, MD, Assistant Professor, Department of Dermatology, School of Medicine and Public Health
Project: Elucidating the metabolic characteristics of sarcoidosis
• Institution: Medical University of Vienna, Austria
Lead investigator: Georg Stary, MD, Principal Investigator, Department of Dermatology
Project: Deciphering the role of FRC-like fibroblasts in cutaneous sarcoidosis
ATF and SPARC also invite independent researchers who are interested in conducting research in sarcoidosis or other granulomatous diseases to explore the new RFP for an upcoming round of funding to be announced mid-year 2026. One-page letters of intent will be accepted through 11:59 p.m. ET on Thursday, October 23, 2025. Funded projects will be eligible for up to $460,000 in funding over two years, and funded projects tied to interdisciplinary research teams will be eligible for up to $575,000 over two years. Potential applicants are encouraged to submit letters of intent regardless of whether they have prior experience in sarcoidosis-specific experience; applicants without experience in sarcoidosis are not required to co-apply with a sarcoidosis expert to qualify for funding.
Sarcoidosis, a debilitating and sometimes fatal inflammatory condition, is marked by abnormal clusters of immune cells in various organs—most frequently in the lungs. In the absence of a cure or even disease-specific treatments, people living with sarcoidosis may experience extreme fatigue, breathing difficulties, joint pain, fever, or eye inflammation. These complications may resolve spontaneously in one to two years for some individuals, while they may be lifelong or recurrent for others.
Due to historically meager funding for sarcoidosis research, few clinicians and researchers study the disease. To change that, ATF and SPARC have partnered since 2020. Among other efforts, they have published a Giving Smarter Guide that identifies strategic opportunities for philanthropic investment in sarcoidosis and launched ATF-BSI, which has since committed over $10 million to sarcoidosis research. To date, more than 20 teams from over 15 institutions have used ATF-BSI’s funding to initiate research aimed at advancing understanding of sarcoidosis’ underlying biology, which is needed to develop novel, effective therapeutics.
“Achieving better treatment and care for sarcoidosis isn’t explained by a lack of scientific interest or by the nature of the disease itself—it’s been limited by insufficient resources and field organization,” said Cara Altimus, PhD, managing director of SPARC. “As each new cohort of funded researchers receives the support they need, we’re proud not only to activate promising research directions but also to grow the nascent community of scientists and clinicians who can build shared knowledge, create resources for the field, and train an upcoming generation of researchers to enable continuous progress for years to come. We believe that better treatments are in sight.”
“With so much about sarcoidosis remaining a mystery—why so many people experience different symptoms of varying severity, sometimes temporarily and sometimes permanently—the medical community is limited in the treatment they can offer,” said Lisa Spalding, spokesperson for the Ann Theodore Foundation. “We must meet this moment by supporting those who seek to answer those questions, as a necessary step toward treating the roots of this debilitating illness.”
Media Contact
Sam Roth
sroth@milkeninstitute.org
About the Milken Institute
The Milken Institute is a nonprofit, nonpartisan think tank focused on accelerating measurable progress on the path to a meaningful life. With a focus on financial, physical, mental, and environmental health, we bring together the best ideas and innovative resourcing to develop blueprints for tackling some of our most critical global issues through the lens of what's pressing now and what's coming next.
Milken Institute Strategic Philanthropy tackles persistent societal challenges by guiding individuals and foundations with the insights and tools to develop strategies, implement giving programs, and foster collaboration to create a better, more equitable world.
The Milken Institute’s Science Philanthropy Accelerator for Research and Collaboration (SPARC) works to develop, launch, and lead initiatives that fund medical research and invest to accelerate the development of tools and treatments that will bring better health to millions of people. We partner with philanthropists, leading them through complex medical research and clinical systems.
About the Ann Theodore Foundation
The Ann Theodore Foundation is a grant-making private foundation that supports a broad range of initiatives, including opportunities for learning and enrichment for young people, food security, climate change mitigation, college access and success, and research towards a cure and improving care for people with sarcoidosis. The Foundation’s philanthropy is informed by the values of compassion, integrity, respect, and community.
END
Milken Institute, Ann Theodore Foundation announce more than $2.5 million in new funding for sarcoidosis research and launch new call for proposals
2025-10-06
ELSE PRESS RELEASES FROM THIS DATE:
Boston University professor to receive 2025 Eugene Braunwald Academic Mentorship Award
2025-10-06
Embargoed until 7 a.m. CT/8 a.m. ET, Monday, Oct. 6, 2025
DALLAS, Oct. 6, 2025 — Emelia J. Benjamin, M.D., FAHA, professor of medicine at Boston University (BU), will receive the 2025 Eugene Braunwald Academic Mentorship Award at the American Heart Association’s Scientific Sessions 2025. The meeting, to be held Nov. 7-10, 2025, in New Orleans, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. Dr. Benjamin will be recognized with the award during the Presidential Session on Sunday, Nov. 9, 2025.
Named for legendary cardiologist Eugene ...
Pusan National University researchers reveal how forest soil properties influence arsenic mobility and toxicity in soil organisms
2025-10-06
Soil contamination is a global environmental concern, with toxic metals and metalloids from industrial activities persisting as long-term pollutants. Arsenic (As), although naturally occurring, becomes widespread when mobilized by mining. Abandoned gold mines are major sources, releasing arsenic-rich minerals into surrounding environments through erosion and leaching. Forest soils, essential for ecosystem health and biodiversity, are particularly vulnerable. Despite arsenic’s mobility under specific soil conditions and known toxicity, its behavior in forest soils and impacts on soil organisms remain poorly understood.
In ...
Korea University researchers find sweet taste cells resist nerve damage through c-Kit protein
2025-10-06
Taste is one of our most vital senses, shaping appetite, nutrition, and quality of life. Yet taste buds are fragile, relying heavily on the nerves that connect them to the brain. When those nerves are cut or damaged, taste buds usually deteriorate — but later regenerate as nerves regrow. How this recovery occurs has remained unclear.
Now, a study led by Dr. Dong-Hoon Kim and Professor Yong Taek Jeong at Korea University College of Medicine, published in the International Journal of Oral Science ...
HealthFORCE, AAPA, and West Health release “Aging Well with AI” – first in a two part series on AI and the healthcare workforce
2025-10-06
Alexandria, Va. — October 6, 2025 — HealthFORCE, a national alliance of leaders dedicated to addressing the root causes of America’s healthcare workforce crisis, along with the American Academy of Physician Associates (AAPA) and West Health, today released “Aging Well with AI: Empowering Care through Innovation,” the first in a two-part white paper series exploring how artificial intelligence (AI) can strengthen the U.S. healthcare workforce and improve access to care. The paper was commissioned by the three ...
The real reasons Endurance sank — study finds Shackleton knew of ship’s shortcomings
2025-10-06
Sir Ernest Shackleton’s ship, Endurance, was crushed by Antarctic sea ice and sank in November 1915. Emblematic of the heroic age of Antarctic exploration, it is widely considered the strongest polar ship of its time, albeit with a fatal flaw — a weakness in the rudder that caused the ship to sink.
Now, a world-first study incorporating both technical analysis and research into diaries and correspondence sheds new light on the expedition and the man himself. Not only did the ship have structural weaknesses that made it notably less robust than other early polar vessels ...
Marine heatwaves have hidden impacts on ocean food webs and carbon cycling
2025-10-06
New research shows that marine heatwaves can reshape ocean food webs, which in turn can slow the transport of carbon to the deep sea and hamper the ocean’s ability to buffer against climate change. The study, published in the scientific journal Nature Communications today, was conducted by an interdisciplinary team of researchers from MBARI, the University of Miami Rosenstiel School of Marine, Atmospheric, and Earth Science, the Hakai Institute, Xiamen University, the University of British Columbia, the University of Southern Denmark, and Fisheries and Oceans Canada.
To explore the impacts of marine heatwaves on ocean food webs and carbon flows, the research team combined multiple ...
Order from disordered proteins
2025-10-06
Key Takeaways
Researchers at Harvard and Northwestern have developed a machine learning method that can design intrinsically disordered proteins with custom properties, addressing nearly 30% of all human proteins that are currently out of reach of AI tools like AlphaFold.
The new approach uses automatic differentiation, traditionally a deep learning tool, to optimize protein sequences for desired properties.
The method opens new possibilities for engineering proteins, directly from physics-based models, that do not fold into a specific shape.
In synthetic and structural biology, advances in artificial intelligence have led to an explosion of designing new proteins with ...
Rocket test proves bacteria survive space launch and re-entry unharmed
2025-10-06
A world-first study has proven microbes essential for human health can survive the extreme forces of space launch.
Space agencies are planning to send crews to Mars within decades but sustaining life on the red planet would be more difficult if important bacteria die during the flight.
Now an Australian-led study has found the spores of Bacilus subtilis, a bacterium essential for human health, can survive rapid acceleration, short-duration microgravity and rapid deceleration.
The spores of bacteria were launched high into ...
New wheat diversity discovery could provide an urgently-needed solution to global food security
2025-10-06
Wheat has a very large and complex genome. Researchers have found that different varieties can use their genes in different ways. By studying RNA—the molecules that carry out instructions from DNA—researchers can see which genes are active and when. By mapping this gene activity for the first time, researchers are able accelerate international wheat breeding programmes, developing new varieties of wheat which can adapt to the rapidly escalating climate emergency.
Wheat is the most widely cultivated crop in the world, with over 215 million hectares grown annually. To meet the demands of a growing global population, plant breeders face ...
Could reducing inflammation help combat fatigue in people with early-stage breast cancer?
2025-10-06
New research reveals that inflammatory responses may play a role in different types of fatigue experienced by many people with cancer. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
Cancer-related fatigue can be a distressing and persistent burden that causes patients to feel physical, emotional, and/or cognitive tiredness or exhaustion. Activation of inflammatory responses by the tumor itself and/or by cancer treatment is thought to be a key biological driver of this symptom, but inflammatory activity across the cancer continuum has not been thoroughly ...